Gamma interferon is essential for clearing Mycobacterium genavense infection

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3720-3723

  Ehlers, Stefan ^a   Richter, Elvira ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; LYMPHADENOPATHY; LYMPHOCYTE ACTIVATION; MONOCYTE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM GENAVENSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; DISEASE SUSCEPTIBILITY; DNA, BACTERIAL; GRANULOMA; HUMANS; INTERFERON TYPE II; LIVER; LYMPHATIC DISEASES; MICE; MICE, KNOCKOUT; MYCOBACTERIUM INFECTIONS; POLYMERASE CHAIN REACTION; SPLEEN;

EID: 0034079248     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3720-3723.2000     Document Type: Article

References (27)

1. Böddinghaus, B., T. Rogall, T. Flohr, H. Blöcker, and E. C. Böttger. 1990. Detection and identification of mycobacteria by amplification of rRNA. J. Clin. Microbiol. 28:1751-1759.
2. Bogdan, C., P. Kern, E. Richter, A. Tannapfel, S. Rüsch-Gerdes, T. Kirchner, and W. Solbach. 1997. Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus. Clin. Infect. Dis. 24:1245-1247.
3. Bosquée, L., E. C. Böttger, H. De Beenhouwer, P. A. Fonteyne, B. Hirschel, L. Larsson, W. M. Meyers, J. C. Palomino, L. Realini, L. Rigouts, M. T. Silva, A. Teske, P. Van der Auwera, and F. Portaels. 1995. Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods. J. Clin. Microbiol. 33:2670-2674.
4. Böttger, E. C., B. Hirschel, and M. B. Coyle. 1993. Mycobacterium genavense sp. nov. Int. J. Syst. Bacteriol. 43:841-843.
5. Böttger, E. C., A. Teske, P. Kirschner, S. Bost, H. R. Chang, V. Beer, and B. Hirschel. 1992. Disseminated Mycobacterium genavense infection in patients with AIDS. Lancet 340:76-80.
6. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
7. Coyle, M. B., L. C. Carlson, C. K. Wallis, R. B. Leonard, V. A. Raisys, J. O. Kilburn, M. Samdadpour, and E. C. Böttger. 1992. Laboratory aspects of Mycobacterium genavense, a proposed species isolated from AIDS patients. J. Clin. Microbiol. 30:32116-3212.
8. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
9. Dorman, S. E., and S. M. Holland. 1998. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J. Clin. Investig. 101:2364-2369.
10. Edwards, U., T. Rogall, H. Blöcker, M. Emde, and E. C. Böttger. 1989. Isolation and direct complete nucleotide determination of entire genes: characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res. 17:7843-7853.
11. Ehlers, S., S. Kutsch, J. Benini, A. Cooper, C. Hahn, J. Gerdes, I. M. Orme, C. Martin, and E. T. Rietschel. 1999. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in M. avium-infected mice without affecting bacterial loads. Immunology 98:313-323.
12. Ehlers, S., and U. Seitzer. 1998. Measuring immune responses in vivo, p. 365-387. In S. H. E. Kaufmann and D. Kabelitz (ed.), Methods in microbiology. Academic Press, London, United Kingdom.
13. Florido, M., A. S. Gonçalves, R. A. Silva, S. Ehlers, A. M. Cooper, and R. Appelberg. 1999. Resistance of virulent Mycobacterium avium to gamma-interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect. Immun. 67:3610-3618.
14. Hänsch, H. C. R., D. A. Smith, M. E. A. Mielke, G. B. Bancroft, and S. Ehlers. 1996. Mechanisms of granuloma formation in murine M. avium infection: the role of CD4+ T cells. Int. Immunol. 8:1299-1310.
15. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J.-F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, and J.-L. Casanova. 1996. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956-1962.
16. Kiehn, T. E., H. Hoefer, E. C. Böttger, R. Ross, M. Wong, F. Edwards, N. Antinoff, and D. Armstrong. 1996. Mycobacterium genavense infection in pet animals. J. Clin. Microbiol. 34:1840-1842.
17. Kirschner, P., U. Vogel, R. Hein, and E. C. Böttger. 1994. Bias of culture techniques for diagnosing mixed Mycobacterium genavense and Mycobacterium avium infection in AIDS. J. Clin. Microbiol. 32:828-831.
18. Leitzke, S., W. Bucke, K. Borner, R. Müller, H. Hahn, and S. Ehlers. 1998. Rationale for and efficacy of intermittent treatment with liposome-encapsulated amikacin in chronically lethal M. avium infection. Antimicrob. Agents Chemother. 42:459-461.
19. Liberek, V., C. Soravia, B. Ninet, B. Hirschel, and C. A. Siegrist. 1996. Cervical lymphadenitis caused by Mycobacterium genavense in a healthy child. Pediatr. Infect. Dis. J. 15:269-270.
20. MacMicking, J., R. North, R. LaCourse, J. Mudgett, S. Shah, and C. F. Nathan. 1997. Identification of NOS2 as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
21. Murray, P. J., R. A. Young, and G. Y. Daley. 1998. Hematopoietic remodeling in interferon-gamma-deficient mice infected with mycobacteria. Blood 91:2914-2924.
22. Pechere, M., M. Opravil, A. Wald, J. P. Chave, M. Bessesen, A. Sievers, R. Hein, J. von Overbeck, H. A. Clark, E. Tortoli, et al. 1995 Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch. Intern. Med. 155:400-404.
23. Realini, L., K. De Ridder, J. Palomino, B. Hirschel, and F. Portaels. 1998. Microaerophilic conditions promote growth of Mycobacterium genavense. J. Clin. Microbiol. 36:2565-2570.
24. Richter, E., U. Greinert, D. Kirsten, S. Rüsch-Gerdes, C. Schlüter, M. Duchrow, J. Galle, H. Magnussen, M. Schlaak, H.-D. Flad, and J. Gerdes. 1996. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am. J. Respir. Crit. Care Med. 153:375-380.
25. Smith, D. A., H. C. R. Hänsch, G. B. Bancroft, and S. Ehlers. 1997. T cell independent mechanisms of granuloma formation in M. avium infection: the role of TNFα and IFNγ. Immunology 92:413-419.
26. Tortoli, E., F. Brunello, A. E. Cagni, D. Colombrita, D. Dionisio, L. Grisendi, V. Manfrin, M. Moroni, C. Passerini Tosi, G. Pinsi, C. Scarparo, and M. T. Simonetti. 1998. Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur. J. Epidemiol. 14:219-224.
27. Vrioni, G., C. Nauciel, G. Kerharo, and P. Matsiota-Bernard. 1998. Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. J. Antimicrob. Chemother. 42:483-487.